全文获取类型
收费全文 | 15415篇 |
免费 | 750篇 |
国内免费 | 50篇 |
专业分类
耳鼻咽喉 | 270篇 |
儿科学 | 1108篇 |
妇产科学 | 492篇 |
基础医学 | 1591篇 |
口腔科学 | 304篇 |
临床医学 | 869篇 |
内科学 | 2888篇 |
皮肤病学 | 432篇 |
神经病学 | 961篇 |
特种医学 | 379篇 |
外国民族医学 | 1篇 |
外科学 | 2493篇 |
综合类 | 347篇 |
一般理论 | 11篇 |
预防医学 | 660篇 |
眼科学 | 667篇 |
药学 | 1487篇 |
中国医学 | 85篇 |
肿瘤学 | 1170篇 |
出版年
2023年 | 99篇 |
2022年 | 237篇 |
2021年 | 464篇 |
2020年 | 267篇 |
2019年 | 326篇 |
2018年 | 391篇 |
2017年 | 323篇 |
2016年 | 396篇 |
2015年 | 429篇 |
2014年 | 589篇 |
2013年 | 794篇 |
2012年 | 1106篇 |
2011年 | 1220篇 |
2010年 | 702篇 |
2009年 | 504篇 |
2008年 | 905篇 |
2007年 | 843篇 |
2006年 | 776篇 |
2005年 | 722篇 |
2004年 | 661篇 |
2003年 | 560篇 |
2002年 | 553篇 |
2001年 | 332篇 |
2000年 | 323篇 |
1999年 | 278篇 |
1998年 | 143篇 |
1997年 | 99篇 |
1996年 | 109篇 |
1995年 | 99篇 |
1994年 | 71篇 |
1993年 | 68篇 |
1992年 | 126篇 |
1991年 | 174篇 |
1990年 | 147篇 |
1989年 | 126篇 |
1988年 | 129篇 |
1987年 | 92篇 |
1986年 | 97篇 |
1985年 | 108篇 |
1984年 | 82篇 |
1983年 | 77篇 |
1981年 | 37篇 |
1979年 | 74篇 |
1978年 | 47篇 |
1977年 | 37篇 |
1973年 | 38篇 |
1972年 | 41篇 |
1971年 | 44篇 |
1970年 | 35篇 |
1968年 | 44篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
Tetrabenazine (TBZ), a presynaptic dopamine depletor and postsynaptic dopamine receptor blocker, is widely used for the treatment of hyperkinetic movement disorders in adults. However, reports of its use in children are limited. We review the efficacy and tolerability of TBZ therapy in 31 children with hyperkinetic movement disorders refractory to other medications. TBZ was effective in reducing the severity of movement disorders resistant to treatment with other medicines. When compared to adult patients, pediatric patients required higher doses. Side effects were similar to the adult population; however, children had a lower incidence of drug-induced Parkinsonism. 相似文献
53.
54.
55.
56.
Dinesh Singh Ajit K. Banerji Bilikere S. Dwarakanath Rajendra P. Tripathi Jaganath P. Gupta T. Lazar Mathew Turuga Ravindranath Viney Jain 《Strahlentherapie und Onkologie》2005,355(1):507-514
Background and Purpose:
Higher rates of glucose utilization and glycolysis generally correlate with poor prognosis in several types of malignant tumors. Own earlier studies on model systems demonstrated that the nonmetabolizable glucose analog 2-deoxy-D-glucose (2-DG) could enhance the efficacy of radiotherapy in a dose-dependent manner by selectively sensitizing cancer cells while protecting normal cells. Phase I/II clinical trials indicated that the combination of 2-DG, at an oral dose of 200 mg/kg body weight (BW), with large fractions of γ-radiation was well tolerated in cerebral glioma patients. Since higher 2-DG doses are expected to improve the therapeutic gain, present studies were undertaken to examine the tolerance and safety of escalating 2-DG dose during combined treatment (2-DG + radiotherapy) in glioblastoma multiforme patients. 相似文献57.
The biophysical mechanisms that drive and regulate cardiac looping are not well understood, but mechanical forces likely play a central role. Previous studies have shown that cardiac torsion, which defines left-right directionality, is caused largely by forces exerted on the heart tube by a membrane called the splanchnopleure (SPL). Here we show that, when the SPL is removed from the embryonic chick heart, torsion is initially suppressed. Several hours later, however, normal torsion is restored. This delayed torsion coincides with increased myocardial stiffness, especially on the right side of the heart. Exposure to the myosin inhibitor Y-27632 suppressed both responses, suggesting that the delayed torsion is caused by an abnormal cytoskeletal contraction. This hypothesis is supported further by computational modeling. These results suggest that the looping embryonic heart has the ability to adapt to changes in the mechanical environment, which may play a regulatory role during morphogenesis. 相似文献
58.
59.
60.
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. 总被引:1,自引:0,他引:1 下载免费PDF全文
S Todo J J Fung T E Starzl A Tzakis H Doyle K Abu-Elmagd A Jain R Selby O Bronsther W Marsh et al. 《Annals of surgery》1994,220(3):297-309
OBJECTIVE: The efficacy for primary orthotopic liver transplantation of a new immunosuppressive agent, FK 506 (tacrolimus, Prograf, Fujisawa USA, Deerfield, IL), was determined. SUMMARY BACKGROUND DATA: After 3 years of preclinical research, a clinical trial of FK 506 for orthotopic liver transplantation was begun in February 1989, first as a rescue therapy for patients with intractable rejection with conventional immunosuppression, then as a primary drug. METHODS: Between August 1989 and December 1993, 1391 recipients (1188 adult and 203 pediatric) of primary liver allografts were treated with FK 506 from the outset. Results from these patients were analyzed and compared with those of 1212 historical control patients (971 adult and 241 pediatric) given cyclosporine-based immunosuppression. RESULTS: Actuarial survival at 4 years was 86.2% with FK 506 versus 65.5% with cyclosporine in the pediatric patients (p < 0.0000) and 71.4% versus 65.5% in the adults (p < 0.0005). The need for retransplantation was reduced significantly for FK 506 patients. Four-year graft survival was 77.0% with FK 506 versus 48.4% with cyclosporine in the pediatric patients (p < 0.0000), and 61.9% with FK 506 versus 51.4% with cyclosporine in the adult recipients (p < 0.0000). Regression analysis revealed that reduction in mortality or graft loss from uncontrollable rejection, sepsis, technical failure, and recurrent original liver disease were responsible for the improved results with FK 506 therapy. CONCLUSIONS: FK 506 is a potent and superior immunosuppressive agent for orthotopic liver transplantation. 相似文献